Global Rofecoxib Market Research Report 2022

Report Format: PDF   |   Report ID: 5379610   |   Published Date: July 2022   |   Pages:  87  

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
    Oral Suspension.
    Tablet-Form
Segment by Application
    Osteoarthritis
    Rheumatoid Arthritis
    Juvenile Rheumatoid Arthritis
    Acute Pain Conditions
    Migraine
    Dysmenorrhea
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E
By Company
    Merck
    Chengdu Meinkai Chemical Co. LTD
    Wuhan Xinxin Jiali Biotechnology Co. LTD
    Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
    Pfizer
    Tremeau
1 Rofecoxib Market Overview
    1.1 Product Overview and Scope of Rofecoxib
    1.2 Rofecoxib Segment by Type
        1.2.1 Global Rofecoxib Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Oral Suspension.
        1.2.3 Tablet-Form
    1.3 Rofecoxib Segment by Application
        1.3.1 Global Rofecoxib Sales Comparison by Application: (2022-2028)
        1.3.2 Osteoarthritis
        1.3.3 Rheumatoid Arthritis
        1.3.4 Juvenile Rheumatoid Arthritis
        1.3.5 Acute Pain Conditions
        1.3.6 Migraine
        1.3.7 Dysmenorrhea
    1.4 Global Rofecoxib Market Size Estimates and Forecasts
        1.4.1 Global Rofecoxib Revenue 2017-2028
        1.4.2 Global Rofecoxib Sales 2017-2028
        1.4.3 Rofecoxib Market Size by Region: 2017 Versus 2021 Versus 2028
2 Rofecoxib Market Competition by Manufacturers
    2.1 Global Rofecoxib Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Rofecoxib Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Rofecoxib Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Rofecoxib Manufacturing Sites, Area Served, Product Type
    2.5 Rofecoxib Market Competitive Situation and Trends
        2.5.1 Rofecoxib Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Rofecoxib Players Market Share by Revenue
        2.5.3 Global Rofecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rofecoxib Retrospective Market Scenario by Region
    3.1 Global Rofecoxib Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Rofecoxib Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Rofecoxib Market Facts & Figures by Country
        3.3.1 North America Rofecoxib Sales by Country
        3.3.2 North America Rofecoxib Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Rofecoxib Market Facts & Figures by Country
        3.4.1 Europe Rofecoxib Sales by Country
        3.4.2 Europe Rofecoxib Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Rofecoxib Market Facts & Figures by Region
        3.5.1 Asia Pacific Rofecoxib Sales by Region
        3.5.2 Asia Pacific Rofecoxib Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Rofecoxib Market Facts & Figures by Country
        3.6.1 Latin America Rofecoxib Sales by Country
        3.6.2 Latin America Rofecoxib Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Rofecoxib Market Facts & Figures by Country
        3.7.1 Middle East and Africa Rofecoxib Sales by Country
        3.7.2 Middle East and Africa Rofecoxib Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Rofecoxib Historic Market Analysis by Type
    4.1 Global Rofecoxib Sales Market Share by Type (2017-2022)
    4.2 Global Rofecoxib Revenue Market Share by Type (2017-2022)
    4.3 Global Rofecoxib Price by Type (2017-2022)
5 Global Rofecoxib Historic Market Analysis by Application
    5.1 Global Rofecoxib Sales Market Share by Application (2017-2022)
    5.2 Global Rofecoxib Revenue Market Share by Application (2017-2022)
    5.3 Global Rofecoxib Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Merck
        6.1.1 Merck Corporation Information
        6.1.2 Merck Description and Business Overview
        6.1.3 Merck Rofecoxib Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Merck Rofecoxib Product Portfolio
        6.1.5 Merck Recent Developments/Updates
    6.2 Chengdu Meinkai Chemical Co. LTD
        6.2.1 Chengdu Meinkai Chemical Co. LTD Corporation Information
        6.2.2 Chengdu Meinkai Chemical Co. LTD Description and Business Overview
        6.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Portfolio
        6.2.5 Chengdu Meinkai Chemical Co. LTD Recent Developments/Updates
    6.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
        6.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Corporation Information
        6.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Description and Business Overview
        6.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Portfolio
        6.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments/Updates
    6.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
        6.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Corporation Information
        6.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Description and Business Overview
        6.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Portfolio
        6.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments/Updates
    6.5 Pfizer
        6.5.1 Pfizer Corporation Information
        6.5.2 Pfizer Description and Business Overview
        6.5.3 Pfizer Rofecoxib Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Pfizer Rofecoxib Product Portfolio
        6.5.5 Pfizer Recent Developments/Updates
    6.6 Tremeau
        6.6.1 Tremeau Corporation Information
        6.6.2 Tremeau Description and Business Overview
        6.6.3 Tremeau Rofecoxib Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Tremeau Rofecoxib Product Portfolio
        6.6.5 Tremeau Recent Developments/Updates
7 Rofecoxib Manufacturing Cost Analysis
    7.1 Rofecoxib Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Rofecoxib
    7.4 Rofecoxib Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Rofecoxib Distributors List
    8.3 Rofecoxib Customers
9 Rofecoxib Market Dynamics
    9.1 Rofecoxib Industry Trends
    9.2 Rofecoxib Market Drivers
    9.3 Rofecoxib Market Challenges
    9.4 Rofecoxib Market Restraints
10 Global Market Forecast
    10.1 Rofecoxib Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Rofecoxib by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Rofecoxib by Type (2023-2028)
    10.2 Rofecoxib Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Rofecoxib by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Rofecoxib by Application (2023-2028)
    10.3 Rofecoxib Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Rofecoxib by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Rofecoxib by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Rofecoxib Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Rofecoxib Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Rofecoxib Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Rofecoxib Market Competitive Situation by Manufacturers in 2021 Table 5. Global Rofecoxib Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Rofecoxib Sales Market Share by Manufacturers (2017-2022) Table 7. Global Rofecoxib Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Rofecoxib Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Rofecoxib Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Rofecoxib Manufacturing Sites and Area Served Table 11. Manufacturers Rofecoxib Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Rofecoxib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rofecoxib as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Rofecoxib Sales by Region (2017-2022) & (K Units) Table 16. Global Rofecoxib Sales Market Share by Region (2017-2022) Table 17. Global Rofecoxib Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Rofecoxib Revenue Market Share by Region (2017-2022) Table 19. North America Rofecoxib Sales by Country (2017-2022) & (K Units) Table 20. North America Rofecoxib Sales Market Share by Country (2017-2022) Table 21. North America Rofecoxib Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Rofecoxib Revenue Market Share by Country (2017-2022) Table 23. Europe Rofecoxib Sales by Country (2017-2022) & (K Units) Table 24. Europe Rofecoxib Sales Market Share by Country (2017-2022) Table 25. Europe Rofecoxib Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Rofecoxib Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Rofecoxib Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Rofecoxib Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Rofecoxib Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Rofecoxib Revenue Market Share by Region (2017-2022) Table 31. Latin America Rofecoxib Sales by Country (2017-2022) & (K Units) Table 32. Latin America Rofecoxib Sales Market Share by Country (2017-2022) Table 33. Latin America Rofecoxib Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Rofecoxib Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Rofecoxib Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Rofecoxib Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Rofecoxib Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Rofecoxib Revenue Market Share by Country (2017-2022) Table 39. Global Rofecoxib Sales by Type (2017-2022) & (K Units) Table 40. Global Rofecoxib Sales Market Share by Type (2017-2022) Table 41. Global Rofecoxib Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Rofecoxib Revenue Share by Type (2017-2022) Table 43. Global Rofecoxib Price by Type (2017-2022) & (USD/Unit) Table 44. Global Rofecoxib Sales (K Units) by Application (2017-2022) Table 45. Global Rofecoxib Sales Market Share by Application (2017-2022) Table 46. Global Rofecoxib Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Rofecoxib Revenue Share by Application (2017-2022) Table 48. Global Rofecoxib Price by Application (2017-2022) & (USD/Unit) Table 49. Merck Corporation Information Table 50. Merck Description and Business Overview Table 51. Merck Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 52. Merck Rofecoxib Product Table 53. Merck Recent Developments/Updates Table 54. Chengdu Meinkai Chemical Co. LTD Corporation Information Table 55. Chengdu Meinkai Chemical Co. LTD Description and Business Overview Table 56. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 57. Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Table 58. Chengdu Meinkai Chemical Co. LTD Recent Developments/Updates Table 59. Wuhan Xinxin Jiali Biotechnology Co. LTD Corporation Information Table 60. Wuhan Xinxin Jiali Biotechnology Co. LTD Description and Business Overview Table 61. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 62. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Table 63. Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments/Updates Table 64. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Corporation Information Table 65. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Description and Business Overview Table 66. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 67. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Table 68. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments/Updates Table 69. Pfizer Corporation Information Table 70. Pfizer Description and Business Overview Table 71. Pfizer Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 72. Pfizer Rofecoxib Product Table 73. Pfizer Recent Developments/Updates Table 74. Tremeau Corporation Information Table 75. Tremeau Description and Business Overview Table 76. Tremeau Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Tremeau Rofecoxib Product Table 78. Tremeau Recent Developments/Updates Table 79. Production Base and Market Concentration Rate of Raw Material Table 80. Key Suppliers of Raw Materials Table 81. Rofecoxib Distributors List Table 82. Rofecoxib Customers List Table 83. Rofecoxib Market Trends Table 84. Rofecoxib Market Drivers Table 85. Rofecoxib Market Challenges Table 86. Rofecoxib Market Restraints Table 87. Global Rofecoxib Sales Forecast by Type (2023-2028) & (K Units) Table 88. Global Rofecoxib Sales Market Share Forecast by Type (2023-2028) Table 89. Global Rofecoxib Revenue Forecast by Type (2023-2028) & (US$ Million) Table 90. Global Rofecoxib Revenue Market Share Forecast by Type (2023-2028) Table 91. Global Rofecoxib Sales Forecast by Application (2023-2028) & (K Units) Table 92. Global Rofecoxib Sales Market Share Forecast by Application (2023-2028) Table 93. Global Rofecoxib Revenue Forecast by Application (2023-2028) & (US$ Million) Table 94. Global Rofecoxib Revenue Market Share Forecast by Application (2023-2028) Table 95. Global Rofecoxib Sales Forecast by Region (2023-2028) & (K Units) Table 96. Global Rofecoxib Sales Market Share Forecast by Region (2023-2028) Table 97. Global Rofecoxib Revenue Forecast by Region (2023-2028) & (US$ Million) Table 98. Global Rofecoxib Revenue Market Share Forecast by Region (2023-2028) Table 99. Research Programs/Design for This Report Table 100. Key Data Information from Secondary Sources Table 101. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Rofecoxib Figure 2. Global Rofecoxib Market Share by Type in 2021 & 2028 Figure 3. Oral Suspension. Product Picture Figure 4. Tablet-Form Product Picture Figure 5. Global Rofecoxib Market Share by Application in 2021 & 2028 Figure 6. Osteoarthritis Figure 7. Rheumatoid Arthritis Figure 8. Juvenile Rheumatoid Arthritis Figure 9. Acute Pain Conditions Figure 10. Migraine Figure 11. Dysmenorrhea Figure 12. Global Rofecoxib Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Rofecoxib Market Size (2017-2028) & (US$ Million) Figure 14. Global Rofecoxib Sales (2017-2028) & (K Units) Figure 15. Rofecoxib Sales Share by Manufacturers in 2021 Figure 16. Global Rofecoxib Revenue Share by Manufacturers in 2021 Figure 17. The Global 5 and 10 Largest Rofecoxib Players: Market Share by Revenue in 2021 Figure 18. Rofecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 19. Global Rofecoxib Sales Market Share by Region (2017-2022) Figure 20. Global Rofecoxib Sales Market Share by Region in 2021 Figure 21. Global Rofecoxib Revenue Market Share by Region (2017-2022) Figure 22. Global Rofecoxib Revenue Market Share by Region in 2021 Figure 23. U.S. Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. Canada Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Germany Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. France Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. U.K. Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Italy Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Russia Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. China Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Japan Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. South Korea Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. India Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Australia Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Taiwan Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Indonesia Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Thailand Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Malaysia Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Philippines Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Vietnam Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Mexico Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Brazil Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Argentina Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Turkey Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Saudi Arabia Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 46. U.A.E Rofecoxib Revenue Growth Rate (2017-2022) & (US$ Million) Figure 47. Sales Market Share of Rofecoxib by Type (2017-2022) Figure 48. Manufacturing Cost Structure of Rofecoxib Figure 49. Manufacturing Process Analysis of Rofecoxib Figure 50. Rofecoxib Industrial Chain Analysis Figure 51. Channels of Distribution Figure 52. Distributors Profiles Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Publisher: QY Research
Choose License

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support